BioCentury
ARTICLE | Company News

Axcan, Aventis deal

October 13, 2003 7:00 AM UTC

AXP acquired North American rights from AVE to duodenal ulcer drug Carafate (Sulcrate in Canada), irritable bowel syndrome (IBS) drug Bentyl (Bentylol in Canada), and hemorrhoidal drug Proctosedyl for...